The companies will work to integrate Prevencio's protein-based blood tests into Quadrant's care pathways to better translate the results into clinical action and measure outcomes.
SYRACUSE, N.Y., Sept. 23, 2020 /PRNewswire/ -- Quadrant Biosciences Inc., a developer of epigenetic diagnostic tools, announced today that it has received an Emergency Use Authorization (EUA) from the ...
Quadrant Biosciences said late Wednesday it received an emergency approval from the Food and Drug Administration for a saliva-based COVID-19 test. The privately held Syracuse, N.Y.-based company ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Tricentis, leader in Continuous Testing and software test automation, today announced that it has been named a Leader in Gartner’s 2019 Magic Quadrant for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback